Skip to content

The Effect of Acupoint Electrical Stimulation on Cerebral Oxygen Metabolism and Postoperative Cognitive Function in Elderly Patients Undergoing Gastrointestinal Surgery

The Effect of Acupoint Electrical Stimulation on Cerebral Oxygen Metabolism and Postoperative Cognitive Function in Elderly Patients Undergoing Gastrointestinal Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000716
Enrollment
Unknown
Registered
2026-03-24
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative cognitive dysfunction(POCD)

Interventions

Acupoint Stimulation Group:Electroacupuncture
Control Group:No stimulation at the acupoint

Sponsors

The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective gastrointestinal surgery, age =65 years, surgical duration >2 hours, ASA class II-III; 2. Patients who are conscious and have normal cognitive function, without deafness, muteness, or severe mental disorders, and are able to follow instructions and cooperate; 3. Patients who have a detailed understanding of the nature, significance, potential benefits, potential inconveniences, and potential risks of the trial, understand the study procedures, and voluntarily sign the informed consent form in writing.

Exclusion criteria

Exclusion criteria: 1. Central nervous system diseases (e.g., Alzheimer's disease); 2. Use of sedatives or antidepressants, alcohol or substance dependence; 3. Severe visual, auditory impairments, or communication disorders, unable to complete neurocognitive function tests; 4. History of cerebrovascular accident within the past three years; 5. Preoperative Mini-Mental State Examination (MMSE) score <23; 6. Patients with severe respiratory diseases; 7. Patients with severe cardiac diseases; 8. Patients with hepatic and renal failure or coagulation disorders; 9. Patients who remain extremely anxious or fearful about surgery despite thorough preoperative communication.

Design outcomes

Primary

MeasureTime frame
Postoperative cognitive function;

Secondary

MeasureTime frame
CRP protein level;Intraoperative cerebral oxygen saturation.;

Countries

China

Contacts

Public ContactWang Xiu Hong

The First Affiliated Hospital of Nanchang University

wangxh19871227@163.com15979166716

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026